|Podcasts|November 1, 2022

Advantages of Precision Endpoints

Author(s)Lisa Henderson
Andy Studna, Senior Editor

Susan Wood, president and CEO of VIDA Diagnostics, discusses her journey into healthcare from an engineering path, changes in the field of imaging, virtual control arms, and much more

Susan Wood, president and CEO of VIDA Diagnostics, discusses her journey into healthcare from an engineering path, changes in the field of imaging, virtual control arms, and much more

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
September 8th 2025
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
August 25th 2025
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
August 20th 2025
ACT Brief Episode 4: New Data on Trial Delays, Hybrid Payment Models, and Managing Complexity
August 18th 2025
ACT Brief Episode 3: Breaking Down Data Silos to Accelerate Clinical Trials
August 13th 2025

Trending on Applied Clinical Trials Online

Latest NIMBLE Study Results Highlight Progress in gMG Research

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

© 2025 MJH Life Sciences^®

All rights reserved.